Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: a RCT
- 737 Downloads
The present randomized, double-blind, placebo-controlled study aimed to evaluate the effect of Zingiber officinale (ginger) consumption on some metabolic and clinical features of obesity.
Eighty eligible obese women (aged 18–45 years) were randomly assigned to either ginger or placebo groups (receiving 2 g/day of ginger powder or corn starch as two 1 g tablets) for 12 weeks. Body mass index (BMI) and body composition were assessed every 4 weeks, and serum levels of leptin, adiponectin, resistin, insulin and glucose were determined before and after intervention. The homeostasis model assessment of insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) were also calculated.
Ginger consumption significantly decreased BMI, serum insulin and HOMA-IR index, along with increasing QUICKIs as compared to the placebo. Moreover, significant reductions in serum leptin, resistin and glucose were observed in both groups, especially in ginger group with nonsignificant differences between groups. The body composition and serum levels of adiponectin were not significantly changed in study groups.
In conclusion, our findings demonstrate a minor beneficial effect of 2 g ginger powder supplementation for 12 weeks on weight loss and some metabolic features of obesity. However, given the lack of data in this area, ongoing clinical trials are needed to further explore ginger’s effectiveness.
KeywordsZingiber officinale Roscoe Obesity Adipocytokines
We wish to express our appreciation to the subjects who participated in the study. We also would like to thank Dr. Samira Pormoradian for technical assistance on biochemical analyses. This study was supported by a Grant from the Research Vice Chancellor and Nutrition Research Center, Tabriz University of Medical Sciences (Tabriz, Iran), with Grant Number (5/71/1353). The results of this article are derived from Ph.D. thesis of Vahideh Ebrahimzadeh Attary (NO, D/32).
Compliance with ethical standards
Conflict of interest
The authors have declared that there is no conflict of interest.
- 5.Koleva DI, Orbetzova MM, Atanassova PK (2013) Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Med 55(1):25–32Google Scholar
- 9.Mashhadi NS, Ghiasvand R, Askari G, Hariri M, Darvishi L, Mofid MR (2013) Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. Int J Prev Med 4(S1):36–42Google Scholar
- 10.Li Y, Tran VH, Duke CC, Roufogalis BD (2012) Preventive and protective properties of Zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Alternat Med 2012:516870Google Scholar
- 13.Pereira MM, Haniadka R, Chacko PP, Palatty PL, Baliga MS (2011) Zingiber officinale Roscoe (ginger) as an adjuvant in cancer treatment: a review. J BUON 16(3):414–424Google Scholar
- 16.Mahmoud RH, Elnour WA (2013) Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats. Eur Rev Med Pharmacol Sci 17(1):75–83Google Scholar
- 21.Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T, Morimitsu Y, Kubota K, Tsuda T (2008) 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated down regulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun 373(3):429–434CrossRefGoogle Scholar
- 22.Okamoto M, Irii H, Tahara Y, Ishii H, Hirao A, Udagawa H, Hiramoto M, Yasuda K, Takanishi A, Shibata S, Shimizu I (2011) Synthesis of a new -gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J Med Chem 54(18):6295–6304CrossRefGoogle Scholar
- 23.Shalaby MA, Saifan HY (2014) Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol 3(4):144–149Google Scholar
- 24.Mansour MS, Ni YM, Roberts AL, Kelleman M, Roychoudhury A, St-Onge MP (2012) Ginger consumption enhances the thermic effect of food and promotes feelings of satiety without affecting metabolic and hormonal parameters in overweight men: a pilot study. Metabolism 61(10):1347–1352CrossRefGoogle Scholar
- 25.Atashak S, Peeri M, Azarbayjani MA, Stannard SR, Mosalman Haghighi M (2011) Obesity-related cardiovascular risk factors after long- term resistance training and ginger supplementation. J Sports Sci Med 10:685–691Google Scholar
- 26.Henríquez S, Jara N, Bunout D, Hirsch S, de la Maza MP, Leiva L, Barrera G (2013) Variability of formulas to assess insulin sensitivity and their association with the Matsuda index. Nutr Hosp 28(5):1594–1598Google Scholar
- 29.Iwasaki Y, Morita A, Iwasawa T, Kobata K, Sekiwa Y, Morimitsu Y, Kubota K, Watanabe T (2006) A nonpungent component of steamed ginger—-shogaol—increases adrenaline secretion via the activation of TRPV1. Nutr Neurosci 9(3–4):169–178Google Scholar
- 31.Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR (2014) The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 22(1):9–16CrossRefGoogle Scholar